Theruptor Novo in Diabetic Foot Ulcer Care: Clinical Outcomes from Three Case Studies
Authors
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Diabetic foot ulcers (DFUs) are a major global health concern, often leading to infection, hospitalization, and in severe cases, limb amputation. This case series explores the clinical outcomes of using Theruptor Novo, an advanced wound dressing, in the management of DFUs in three patients. Each patient presented with chronic wounds of varying sizes and severities, all of which showed consistent and progressive healing following treatment with Theruptor Novo. The dressing demonstrated significant reductions in wound size, promoted healthy granulation tissue formation, and effectively prevented infection without signs of adverse reactions. Notably, no redness, exudate, or swelling was observed during follow-ups, and patients reported reduced pain and high satisfaction with the treatment. These findings suggest that Theruptor Novo is a promising and patient-friendly option for DFU care.
##plugins.themes.bootstrap3.article.details##
Copyright (c) 2025 Dr B Harish Kumar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons License All articles published in Annals of Medicine and Medical Sciences are licensed under a Creative Commons Attribution 4.0 International License.
Dr B Harish Kumar, Consultant Physician in Diabetes & Endocrinology, Darla’s Health Care, Mysuru, Karnataka, India
Consultant Physician in Diabetes & Endocrinology, Darla’s Health Care, Mysuru, Karnataka, India
[1] Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017 Jun 15;376(24):2367–75.
[2] Zhang Y, Lazzarini PA, McPhail SM, van Netten JJ, Armstrong DG, Pacella RE. Global Disability Burdens of Diabetes-Related Lower-Extremity Complications in 1990 and 2016. Diabetes Care. 2020 May;43(5):964–74.
[3] Lavery LA, Suludere MA, Attinger CE, Malone M, Kang GE, Crisologo PA, et al. WHS (Wound Healing Society) guidelines update: Diabetic foot ulcer treatment guidelines. Wound Repair Regen. 2024;32(1):34–46.
[4] Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic Foot Ulcers. JAMA [Internet]. 2023 Jul 3 [cited 2025 Apr 4];330(1):62–75. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10723802/
[5] Noor S, Zubair M, Ahmad J. Diabetic foot ulcer--A review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr. 2015;9(3):192–9.
[6] Noor S, Khan RU, Ahmad J. Understanding Diabetic Foot Infection and its Management. Diabetes & Metabolic Syndrome: Clinical Research & Reviews [Internet]. 2017 Apr 1 [cited 2024 Sep 23];11(2):149–56. Available from: https://www.sciencedirect.com/science/article/pii/S1871402116301291
[7] Bader MS. Diabetic Foot Infection. afp [Internet]. 2008 Jul 1 [cited 2025 Apr 4];78(1):71–9. Available from: https://www.aafp.org/pubs/afp/issues/2008/0701/p71.html
[8] Jiang P, Li Q, Luo Y, Luo F, Che Q, Lu Z, et al. Current status and progress in research on dressing management for diabetic foot ulcer. Front Endocrinol (Lausanne) [Internet]. 2023 Aug 17 [cited 2025 Apr 4];14:1221705. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470649/
[9] Gupta R, Murthy KS, Bhagavan KR, Moharana AK, Rodrigues M, Ts D. Antimicrobial properties of Theruptor 3D-hydrocellular wound dressing: Anin vitrostudy. International Journal of Surgery Open [Internet]. 2022 Sep [cited 2025 Jun 10]; 46:100528. Available from: https://journals.lww.com/ijsopen/fulltext/2022/46000/antimicrobial_properties_of_theruptor.7.aspx
[10] Pavan B. Theruptor novo: wound dressing for diabetic foot ulcer. International Surgery Journal [Internet]. 2023 Nov 10 [cited 2025 Jun 10];10(12):2010–2. Available from: https://www.ijsurgery.com/index.php/isj/article/view/10046
[11] Ray R, Sarkar R, Gupta S, Halder T. Trushield NXT Non Adherent Wound Dressing versus Standard of Care Dressing among Women Undergoing Obstetric and Gynaecological Surgeries: A Randomised Clinical Study. JCDR [Internet]. 2022 [cited 2025 Jun 10]; Available from: https://www.jcdr.net//article_fulltext.asp?issn=0973-709x&year=2022&volume=16&issue=12&page=QC27&issn=0973-709x&id=17350
[12] Kale SM. Theruptor Novo, a novel wound dressing in the management of infected diabetic foot ulcer: two case reports. International Journal of Advances in Medicine [Internet]. 2024 [cited 2025 Jun 10];11(1):43–6. Available from: https://www.ijmedicine.com/index.php/ijam/article/view/3958
[13] Sampath J. Superficial Partial Thickness Burns Treated using Theruptor Novo, a Novel Antimicrobial Dressing: A Case Report. JCDR [Internet]. 2024 [cited 2025 Jun 10]; Available from: https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2024&month=August&volume=18&issue=8&page=PD01-PD02&id=19715